Business Context and Reporting Period
Company: Eastman Chemical Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2006
Overview: Eastman is a global chemical company manufacturing chemicals, plastics, and fibers across five operating segments: CASPI, Fibers, Performance Chemicals and Intermediates (PCI), Performance Polymers, and Specialty Plastics (SP). The company operates 16 manufacturing sites in 10 countries. In 2006, Eastman achieved record sales revenue of $7.5 billion but reported a decline in operating earnings due to higher raw material costs, lower selling prices in the Performance Polymers segment, and significant restructuring charges.
Key Financial Metrics
| Metric (in millions, except per share) | 2006 | 2005 |
|---|---|---|
| Sales Revenue | $7,450 | $7,059 |
| Gross Profit | $1,277 | $1,404 |
| Gross Margin | 17.1% | 19.9% |
| Operating Earnings | $640 | $757 |
| Net Earnings | $409 | $557 |
| Diluted EPS | $4.91 | $6.81 |
| Cash from Operating Activities | $609 | $769 |
| Capital Expenditures | $389 | $343 |
| Long-term Borrowings | $1,589 | $1,621 |
| Cash and Cash Equivalents | $939 | $524 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 6% to $7.45 billion, driven primarily by higher selling prices (5% effect) and volume (2% effect) to offset rising raw material and energy costs, which increased by approximately $400 million year-over-year.
- Profitability Decline: Operating earnings decreased 15% to $640 million. This was primarily due to lower results in the Performance Polymers segment, where lower industry capacity utilization led to lower selling prices for PET polymers despite higher input costs.
- Restructuring and Impairments: The company recorded $101 million in asset impairments and restructuring charges in 2006 (compared to $33 million in 2005). This included $10 million in accelerated depreciation related to restructuring decisions.
- Divestitures: In Q4 2006, Eastman divested its Batesville, Arkansas facility (PCI segment) and its polyethylene (PE) and Epolene polymer businesses (Performance Polymers and CASPI segments). These divested lines generated $811 million in sales and $124 million in operating earnings in 2006. The sales generated a net gain of $68 million in other operating income.
- Cash Flow: Operating cash flow decreased $160 million to $609 million, attributed to lower net earnings and a $128 million increase in working capital requirements, partially offset by lower pension contributions.
Guidance, Outlook, and Risks
- 2007 Outlook: Management expects strong volumes maintained by economic strength and product substitution. However, volatility in raw material and energy costs is expected to continue.
- Capital Spending: 2007 capital expenditures are projected to be up to $450 million, exceeding estimated depreciation and amortization of $350 million (including $50 million in accelerated depreciation).
- Strategic Initiatives:
- Performance Polymers: Aggressive actions to improve PET profitability, including the start-up of a new IntegRex technology facility in South Carolina (full capacity expected Q1 2007) and the sale of the San Roque, Spain facility.
- Specialty Plastics: Commercialization of a new family of copolyesters by the end of 2007.
- Coal Gasification: Continued efforts to increase product volume derived from coal to approximately 50% to secure cost advantages.
- Risks and Contingencies:
- Raw Material Costs: Significant exposure to fluctuations in propane, natural gas, and coal prices.
- Legal Proceedings: Ongoing sorbates litigation (appeals pending) and asbestos litigation (management believes resolution will not be material).
- Environmental: Estimated future environmental expenditures for remediation range from $18 million to $32 million.
- Pension Obligations: The company contributed $100 million to its U.S. defined benefit pension plan in Q1 2007.
Key Facts for Investor Verification
- Performance Polymers Turnaround: Verify the operational status and cost savings of the new IntegRex facility in South Carolina and the timeline for the sale of the San Roque, Spain facility.
- Raw Material Hedging: Assess the effectiveness of hedging strategies in mitigating the impact of volatile energy and raw material costs on gross margins.
- Divestiture Proceeds: Confirm the final purchase price and working capital adjustments for the PE/Epolene and Batesville facility sales, as estimates may change.
- Restructuring Costs: Monitor the execution of the $101 million in restructuring charges and the associated cash outflows for severance and site closures.
- Capital Allocation: Track the $450 million capital expenditure plan against the $350 million depreciation estimate to ensure growth initiatives are funded without compromising liquidity.